Arlington Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.5K | Hold |
140
| – | – | 0.01% | 307 |
|
|
2025
Q1 | $88.8K | Hold |
140
| – | – | 0.02% | 283 |
|
|
2024
Q4 | $99.7K | Hold |
140
| – | – | 0.02% | 270 |
|
|
2024
Q3 | $147K | Hold |
140
| – | – | 0.03% | 210 |
|
|
2024
Q2 | $147K | Buy |
+140
| New | +$147K | 0.03% | 190 |
|
|
2024
Q1 | – | Sell |
-7
| Closed | -$6.15K | – | 805 |
|
|
2023
Q4 | $6.15K | Buy |
7
+4
| +133% | +$3.51K | ﹤0.01% | 450 |
|
|
2023
Q3 | $2.47K | Buy |
+3
| New | +$2.47K | ﹤0.01% | 270 |
|